Table 1.

Radiation recall phenomenon after administration of SARS-CoV-2 vaccine

Report	Age	sex	Type of vaccine	Vaccinations	primary tumor	Tumor site	Radiation dose (to tumor) (Gy)	Time interval (end of radiotherapy to 1st vaccination)	Time to onset of skin reaction (final vaccination to skin reaction)	Severity of skin reaction
Soyfer V et al.	68	male	Pfizer-BioNTech (mRNA vaccine)	Twice	Unclassified spindle cell sarcoma	Back	50	175 days	5 days	Mild
Soyfer V et al.	64	Male	Pfizer-BioNTech (mRNA vaccine)	Twice	Solitary fibrous tumor	Chest wall	39	11 days	6 days	Mild
Afacan E et al.	60	Female	Sinopharm (inactivated virus vaccine)	Twice	Melanoma	Leg	30	39 months	5 days	Mild
Stewart R et al.	57	Female	AstraZeneca (vector vaccine)	Once	Acinic cell carcinoma	Parotid gland	66	6 months	3 weeks	Mild
Present case	51	Female	Moderna (mRNA vaccine)	Once	Invasive ductal carcinoma	Breast	60	30 days	7 days	Mild